share_log

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

4:持股變動聲明-高管 Sragovicz Adam
美股SEC公告 ·  05/15 22:26

Moomoo AI 已提取核心訊息

Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Conduit Pharmicals首席財務官亞當·斯拉戈維奇已於2024年5月15日開始處置74,545個限制性股票單位(RSU)。該交易目前正在進行中,涉及該公司的普通股。限制性股票單位已免費出售,交易完成後,Sragovicz將持有該公司的零股份。此舉可能預示着公司財務領導層或戰略的變化。
Conduit Pharmicals首席財務官亞當·斯拉戈維奇已於2024年5月15日開始處置74,545個限制性股票單位(RSU)。該交易目前正在進行中,涉及該公司的普通股。限制性股票單位已免費出售,交易完成後,Sragovicz將持有該公司的零股份。此舉可能預示着公司財務領導層或戰略的變化。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息